ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.902,42
1,63%
S&P 500
6.083,57
0,36%
Dow Jones
44.747,63
-0,28%
Euro vs US Dollar
1,03865
-0,13%
Bitcoin
96.219,07
-0,42%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Europa
  5. EU

  6. Galapagos (GLPG) Börsenkurse

Galapagos

Galapagos (GLPG)

Galapagos NV
22,28
0,42
(1,92%)
Geschlossen 06 Februar 5:30PM
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
22,28
Gebot
22,00
Fragen
22,34
Volumen
77.505
21,90 Tagesbereich 22,36
21,76 52-Wochen-Bereich 37,17
Marktkapitalisierung
1,468B
Handelsende
21,86
Handelsbeginn
21,98
Letzte Trade
44
@
22.28
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
118.443
Ausgegebene Aktien
65.897.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
6,94
Gewinn pro Aktie (EPS)
3,21
Erlöse
843,8M
Nettogewinn
211,7M

Über Galapagos

Sektor
Coml Physical, Biologcl Resh
Branche
Coml Physical, Biologcl Resh
Website
www.glpg.com
Hauptsitz
Mechelen, Antwerp, Bel
Gegründet
-
Galapagos is listed in the Coml Physical, Biologcl Resh sector of the Euronext with ticker GLPG. The last closing price for Galapagos was 21,86 €. Over the last year, Galapagos shares have traded in a share price range of 21,76 € to 37,17 €.

Galapagos currently has 65.897.000 shares in issue. The market capitalisation of Galapagos is 1,44 € billion. Galapagos has a price to earnings ratio (PE ratio) of 6.94.

GLPG Neueste Nachrichten

Weitere Nachrichten

Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities

Galapagos intends to create a new company with approximately €2.45 billion in cash dedicated to building a pipeline of innovative medicines through transformational transactions Galapagos will...

08 Januar 2025
GlobeNewswire Inc.

Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities

Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities Galapagos intends to create a new company with approximately €2.45 billion in cash...

08 Januar 2025
UK Regulatory

Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare Conference Mechelen, Belgium; January 7, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the Company...

07 Januar 2025
UK Regulatory

Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Mechelen, Belgium; January 7, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the Company will present at the 43rd Annual J.P. Morgan Healthcare Conference on...

07 Januar 2025
GlobeNewswire Inc.

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma Data from the ongoing Phase...

07 Dezember 2024
UK Regulatory

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

Data from the ongoing Phase 1/2 ATALANTA-1 study in a heavily pretreated R/R NHL patient population demonstrate high antitumor activity and an encouraging safety profile in all NHL subtypes...

07 Dezember 2024
GlobeNewswire Inc.

Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024

New Phase 1/2 data support the potential of our CAR T-cell therapy candidates, GLPG5101 and GLPG5201, in addressing unmet needs for patients with poor prognoses. Our innovative decentralized cell...

05 November 2024
GlobeNewswire Inc.

Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024

Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024 New Phase 1/2 data support the potential of our CAR T-cell therapy candidates, GLPG5101 and GLPG5201, in...

05 November 2024
UK Regulatory

Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update

Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update We are advancing our pipeline and accelerating innovation through focused execution of our Forward, Faster...

30 Oktober 2024
UK Regulatory

Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update

We are advancing our pipeline and accelerating innovation through focused execution of our Forward, Faster strategy.We are committed to addressing the high unmet needs of patients through a...

30 Oktober 2024
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10022.2822.5421.769040722.14719626DE
4-3.92-14.961832061126.226.821.7613249223.35261424DE
12-3.52-13.643410852725.831.0821.7611844325.11340389DE
26-1.16-4.9488054607523.4431.0821.7611074125.44928762DE
52-13.04-36.91959229935.3237.1721.769643726.50716305DE
156-35.77-61.619293712358.0566.2821.7614809840.98252878DE
260-201.72-90.0535714286224252.921.7627640985.24840135DE

GLPG - Frequently Asked Questions (FAQ)

What is the current Galapagos share price?
The current share price of Galapagos is 22,28 €
How many Galapagos shares are in issue?
Galapagos has 65.897.000 shares in issue
What is the market cap of Galapagos?
The market capitalisation of Galapagos is EUR 1,44B
What is the 1 year trading range for Galapagos share price?
Galapagos has traded in the range of 21,76 € to 37,17 € during the past year
What is the PE ratio of Galapagos?
The price to earnings ratio of Galapagos is 6,94
What is the cash to sales ratio of Galapagos?
The cash to sales ratio of Galapagos is 1,74
What is the reporting currency for Galapagos?
Galapagos reports financial results in EUR
What is the latest annual turnover for Galapagos?
The latest annual turnover of Galapagos is EUR 843,8M
What is the latest annual profit for Galapagos?
The latest annual profit of Galapagos is EUR 211,7M
What is the registered address of Galapagos?
The registered address for Galapagos is GENERAAL DE WITTELAAN L11, MECHELEN, ANTWERP, A3 2800
What is the Galapagos website address?
The website address for Galapagos is www.glpg.com
Which industry sector does Galapagos operate in?
Galapagos operates in the COML PHYSICAL, BIOLOGCL RESH sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ALCYBCybergun
0,0002 €
(100,00%)
12,48M
MLWEYWeya
0,027 €
(68,75%)
2k
ALENTEntreparticuliersCom
0,75 €
(52,13%)
90,71k
GIM32Gimv NV
0,65 €
(37,71%)
477,35k
ALSASStradim Espac Fin
6,90 €
(33,98%)
2k
CLEXCumulex NV
0,585 €
(-55,68%)
738
SOISOITEC
57,70 €
(-29,72%)
1,92M
TUVDSBio UV Group DS
0,0231 €
(-29,36%)
620,29k
ALALOAcheterLouerFR
0,0227 €
(-29,06%)
2,7M
MLOCTOctopus Biosafety
0,144 €
(-25,39%)
10,36k
ATOAtos SE
0,0021 €
(0,00%)
402,51M
ALVERVergnet
0,0007 €
(-22,22%)
70,45M
INGAING Groep NV
15,92 €
(-0,29%)
22,66M
BCPBanco Comercial Portugues SA
0,5066 €
(2,76%)
18,96M
ALNRGEnergisme SA
0,0037 €
(12,12%)
17,17M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

EU
GLPG
Galapagos
NEO
EARK.U
Emerge Ark Global Disrup...
FTSE
MCX
FTSE 250
USOTC
AFLYY
Air France ADS (PK)
BIT
UC4VD5
Unicredit Bank
BIT
F34610
Vontobel Financial Produ...
BIT
I05220
Banca IMI
BIT
UI272B
Unicredit Bank
BIT
F12521
Vontobel Financial Produ...
BIT
UB4QBG
Unicredit Bank
BIT
F28873
Vontobel Financial PIssuer
BIT
CLOU
Global X Cloud Computing...
BIT
ALV
Allianz
AQSE
RIOL.GB
Amundi MSCI Brazil UCITS...
BIT
I09012
Intesa Sanpaolo
BIT
UC7PXM
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten